Clinical Trials List
Protocol NumberDR-0201-ONC-001
Active
2024-06-01 - 2027-07-31
Phase I
Recruiting3
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ta-Chih Liu 無
- 吳敬炫 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Ju Wu 無
- Chien-Chin Lin 無
- 劉高郎 無
- 李思慧 無
- HSIN-AN HOU 無
- BANG-BIN CHEN 無
- Chieh-Lung Cheng 無
- SHAN-CHI YU 無
- Wen-Chien Chou 無
- MING YAO 無
- Tai-Chung Huang 無
- 田豐銘 無
- 林明恩 無
- 柯紀綸 無
- Huai-Hsuan Huang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
7 participants
-
Global
96 participants
